QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 专题：吉林大学白求恩第一医院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6 作者:  Geater, Sarayut L.;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Afatinib  Non-small-cell lung cancer  Progression-free survival  Patient-reported outcomes  Quality of life   Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial 期刊论文 LANCET ONCOLOGY, 2014, 卷号: 15, 期号: 2 作者:  Geater, Sarayut L.;  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) versus gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M plus ) advanced adenocarcinoma of the lung. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Hou, Mei;  Wu, Yi Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Ji Feng 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 会议论文 作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Lung cancer / Oncology   LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 期刊论文 EUROPEAN RESPIRATORY JOURNAL, 2013, 卷号: 42 作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 LUX-Lung 6: Patient-reported outcomes (PROs) from a randomized open-label, phase III study in first-line advanced NSCLC patients (pts) harboring epidermal growth factor receptor (EGFR) mutations 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Geater, Sarayut Lucien;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Ji Feng;  Lu, Shun 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05